{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259332226", "close" : "1259344826", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
ap

Somanetics signs licensing deal with Raba Equity

Somanetics signs licensing deal with Raba Equity for monitoring technology

  • On 12:09 pm EDT, Wednesday October 14, 2009

TROY, Mich. (AP) -- Medical device maker Somanetics Corp. said Wednesday it signed a licensing deal with Raba Equity Partners II LLC, gaining diagnostic monitoring technology for $1.8 million in upfront payments, plus future royalties.

Under the deal, the company acquired an exclusive sublicense to cerebral autoregulation monitoring technology developed at The Johns Hopkins University. Cerebral autoregulation refers to the body's ability to maintain constant blood flow to the brain despite changes in blood pressure.

Shares of Somanetics rose 5 cents to $16.72 in midday trading.

Related Headlines

Top Stories

Related Message Boards

Sponsored Links

Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.